Oncology Invest Information

Pharmaceuticals
AstraZeneca Pharma Gains CDSCO Approval for Durvalumab Importation Sep 25, 2024
Pharmaceuticals
Novartis's Kisqali Demonstrates a 28.5% Decrease in Recurrence Risk in Early Breast Cancer Patients Sep 17, 2024
Companies
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma Apr 29, 2024
Companies
BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026 Mar 20, 2024
Companies
Mainz Biomed Launches Physician-Led Lab in Germany Targeting Privately Insured Patients Feb 7, 2024
Companies
SOPHiA GENETICS Partners with Karkinos Healthcare to Transform Cancer Care in India Jan 15, 2024
Companies
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial Jan 8, 2024
Companies
Bristol Myers Squibb's Repotrectinib Under EMA Review for NSCLC Treatment Jan 4, 2024
Companies
Alpha Tau Medical Highlights Landmark Achievements at J.P. Morgan Healthcare Conference Dec 20, 2023
Companies
Alpha Tau Medical to Showcase Advances at the Upcoming J.P. Morgan Healthcare Conference Dec 20, 2023
Stock Market Movers: Space, Entertainment, and Pharma Shares See Major Activity Nov 9, 2023